Calcipotriene/betamethasone dipropionate foam: primary evidence supporting its use in patients with psoriasis vulgaris. A narrative review

Psoriasis vulgaris is a chronic, immune-mediated disorder, which has a substantial impact on all aspects of patients’ quality of life. In most patients, the disease is mild to moderate and is successfully treated with topical agents. The most common therapy involves a vitamin D3 analogue (calcipotri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Advances in Dermatology and Allergology
Main Authors: Joanna Narbutt, Rafał Czajkowski, Aleksandra Lesiak, Witold Owczarek, Adam Reich, Jacek Szepietowski
Formato: Artigo
Publicado em: Termedia Publishing House 2021-11-01
Assuntos:
Psoriasis vulgaris
calcipotriene
betamethasone dipropionate
foam
topical administration
Acesso em linha:https://www.termedia.pl/Calcipotriene-betamethasone-dipropionate-foam-r-nprimary-evidence-supporting-its-use-in-patients-r-nwith-psoriasis-vulgaris-A-narrative-review,7,45455,1,1.html
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Internet

https://www.termedia.pl/Calcipotriene-betamethasone-dipropionate-foam-r-nprimary-evidence-supporting-its-use-in-patients-r-nwith-psoriasis-vulgaris-A-narrative-review,7,45455,1,1.html

Registos relacionados